Events
Meet us at
Embedded Files
2026
2026
Healthcare Innovation Forum
Healthcare Innovation Forum
Rome, Italy, March 28, 2026
https://healthcareinnovationforum.itHealthcare is undergoing a profound transformation. Innovation, technology, and new organizational models are redefining how we design and sustain the medicine of the future—more personalized, integrated, and preventive. In this context, the Healthcare Innovation Forum stands as a shared space for dialogue and co‑design among institutions, professionals, and industry.
https://healthcareinnovationforum.itHealthcare is undergoing a profound transformation. Innovation, technology, and new organizational models are redefining how we design and sustain the medicine of the future—more personalized, integrated, and preventive. In this context, the Healthcare Innovation Forum stands as a shared space for dialogue and co‑design among institutions, professionals, and industry.
BIOTECHGATE DIGITAL PARTNERING
BIOTECHGATE DIGITAL PARTNERING
Feb 23-27, 2026
Biotechgate Digital PartneringBiotechgate Digital Partnering is designed to support the business development & licensing of Pharma, Biotech, Medtech and Digital Health companies. Join five days of virtual partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings in our business forum.
Biotechgate Digital PartneringBiotechgate Digital Partnering is designed to support the business development & licensing of Pharma, Biotech, Medtech and Digital Health companies. Join five days of virtual partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings in our business forum.
2025
2025
AI in Clinical Trials
AI in Clinical Trials
Nov 6, 2025
AI in Clinical TrialsArtificial Intelligence (AI) is rapidly changing Medicine, especially oncology: it offers groundbreaking tools to optimize clinical trial design, improve patient selection, accelerate fact collection from real-world data, increase clinical experimentation in efficiency, and maximize of innovative pharmacological treatments, e. g. immunotherapy and targeted therapy.
AI in Clinical TrialsArtificial Intelligence (AI) is rapidly changing Medicine, especially oncology: it offers groundbreaking tools to optimize clinical trial design, improve patient selection, accelerate fact collection from real-world data, increase clinical experimentation in efficiency, and maximize of innovative pharmacological treatments, e. g. immunotherapy and targeted therapy.
Biotechgate Digital Partnering
Biotechgate Digital Partnering
Dec 8 – 12, 2025
https://biotechgate.comAI offers powerful tools but is not a cure-all. Its success relies on high-quality input data, advanced algorithms, and, crucially, the expertise and intuition of human researchers guiding its application. While AI is revolutionizing drug development by potentially enhancing the Probability of Success and Likelihood of Approval, we should temper expectations with the understanding that current successes are based on a limited range of use cases
https://biotechgate.comAI offers powerful tools but is not a cure-all. Its success relies on high-quality input data, advanced algorithms, and, crucially, the expertise and intuition of human researchers guiding its application. While AI is revolutionizing drug development by potentially enhancing the Probability of Success and Likelihood of Approval, we should temper expectations with the understanding that current successes are based on a limited range of use cases
ELRIG’s Drug Discovery 2025
ELRIG’s Drug Discovery 2025
Oct 21 – 22, 2025 - Liverpool, UK
Drug Discovery 2025 - EuropeELRIG Drug Discovery 2025 returns to Liverpool as Europe’s leading life sciences conference, featuring topics like robotics, cell models, ‘omics, AI, oncology, and neurodegenerative diseases. With partners such as SLAS and the Royal Society of Chemistry, the event offers free access, inclusive spaces, and a central exhibition hall for networking with top experts and suppliers in drug discovery.
Drug Discovery 2025 - EuropeELRIG Drug Discovery 2025 returns to Liverpool as Europe’s leading life sciences conference, featuring topics like robotics, cell models, ‘omics, AI, oncology, and neurodegenerative diseases. With partners such as SLAS and the Royal Society of Chemistry, the event offers free access, inclusive spaces, and a central exhibition hall for networking with top experts and suppliers in drug discovery.
Healthcare Innovation Summit
Healthcare Innovation Summit
Oct 8-9-10, 2025 - Magna Pars Event Space - Milano
Healthcare Innovation SummitThis Summit is part of a comprehensive program of joint initiatives in the field of training and cultural dissemination on digital innovation. This initiative has resulted in a document containing Guidelines on the Application of NIS2 in Healthcare, which will be presented at the Healthcare Innovation Summit 2025. The Healthcare Innovation Summit 2025, the leading digital innovation event in the healthcare and life sciences ecosystem, also benefited from contributions shared by Alberto Traverso.
Healthcare Innovation SummitThis Summit is part of a comprehensive program of joint initiatives in the field of training and cultural dissemination on digital innovation. This initiative has resulted in a document containing Guidelines on the Application of NIS2 in Healthcare, which will be presented at the Healthcare Innovation Summit 2025. The Healthcare Innovation Summit 2025, the leading digital innovation event in the healthcare and life sciences ecosystem, also benefited from contributions shared by Alberto Traverso.
Lab of the Future - Europe
Lab of the Future - Europe
Sept 30 – Oct 1, 2025
Lab of the Future - EuropeThe Lab of the Future Congress series interrogates the latest advances and drivers shaping life science research, development and manufacturing, and how these advances can be harnessed to deliver much needed therapeutics at pace and scale. The Congress focuses on the changing nature of the modern research environment, the role of new and emerging technologies and modalities, and the shift to a more collaborative research culture. Our format of curated content, lightening talks, and discussion sessions delivers thought leadership, open discussion, and high levels of audience participation.
Lab of the Future - EuropeThe Lab of the Future Congress series interrogates the latest advances and drivers shaping life science research, development and manufacturing, and how these advances can be harnessed to deliver much needed therapeutics at pace and scale. The Congress focuses on the changing nature of the modern research environment, the role of new and emerging technologies and modalities, and the shift to a more collaborative research culture. Our format of curated content, lightening talks, and discussion sessions delivers thought leadership, open discussion, and high levels of audience participation.
AI-powered drug discovery
AI-powered drug discovery
Sept 18, 2025 - 03:00PM CEST
AI-powered drug discovery: Accelerating the development of life-saving therapiesAI in drug discovery is no longer theoretical. It’s already speeding up target identification, improving predictions, and cutting waste. Learn how to apply it in your own discovery pipeline. In this expert-led webinar, Dr Remco Jan Geukes Foppen will share practical insights into how AI is being applied across the pharmaceutical sector, helping teams move faster and make better-informed decisions. He will address how to gain transparency into AI’s decision-making processes, allowing for greater trust and more robust scientific validation. With experience spanning data management, image analysis, bioinformatics and machine learning in clinical research, he brings both deep technical expertise and strategic understanding of real-world challenges.
AI-powered drug discovery: Accelerating the development of life-saving therapiesAI in drug discovery is no longer theoretical. It’s already speeding up target identification, improving predictions, and cutting waste. Learn how to apply it in your own discovery pipeline. In this expert-led webinar, Dr Remco Jan Geukes Foppen will share practical insights into how AI is being applied across the pharmaceutical sector, helping teams move faster and make better-informed decisions. He will address how to gain transparency into AI’s decision-making processes, allowing for greater trust and more robust scientific validation. With experience spanning data management, image analysis, bioinformatics and machine learning in clinical research, he brings both deep technical expertise and strategic understanding of real-world challenges.
Biotechgate Digital Partnering
Biotechgate Digital Partnering
Aug 25 – 29, 2025
https://biotechgate.comAI offers powerful tools but is not a cure-all. Its success relies on high-quality input data, advanced algorithms, and, crucially, the expertise and intuition of human researchers guiding its application. While AI is revolutionizing drug development by potentially enhancing the Probability of Success and Likelihood of Approval, we should temper expectations with the understanding that current successes are based on a limited range of use cases
https://biotechgate.comAI offers powerful tools but is not a cure-all. Its success relies on high-quality input data, advanced algorithms, and, crucially, the expertise and intuition of human researchers guiding its application. While AI is revolutionizing drug development by potentially enhancing the Probability of Success and Likelihood of Approval, we should temper expectations with the understanding that current successes are based on a limited range of use cases
AI for Oncology
AI for Oncology
MILAN, ITALY, 8-9 MAY 2025
https://www.aiforoncology.itAbstract 1:
Semantic Explainability in Oncological Decision Support: Enhancing Clinical Trust Through Transparent AI Systems.
Vincenzo Gioia, Remco Jan Geukes Foppen, Alberto Traverso.Abstract 2:
Regulatory Framework for Language Models in Oncology.
Remco Jan Geukes Foppen, Vincenzo Gioia, Alberto Traverso.
https://www.aiforoncology.itAbstract 1:
Semantic Explainability in Oncological Decision Support: Enhancing Clinical Trust Through Transparent AI Systems.
Vincenzo Gioia, Remco Jan Geukes Foppen, Alberto Traverso.Abstract 2:
Regulatory Framework for Language Models in Oncology.
Remco Jan Geukes Foppen, Vincenzo Gioia, Alberto Traverso.
Healthcare Innovation Executive Conference
Rome, Italy, May 6, 2025
https://www.theinnovationgroup.it Explainambiguity Think Tank affronta le ambiguità dell’IA nei settori farmaceutico e sanitario, promuovendo chiarezza, innovazione e conformità normativa. Mira a rafforzare fiducia, trasparenza ed efficienza, trasformando le complessità in opportunità di crescita. L’obiettivo è un futuro sanitario più sicuro e innovativo, guidato dalla comprensione e dall’applicazione responsabile dell’IA.
Vincenzo Gioia, Remco Jan Geukes Foppen.
https://www.theinnovationgroup.it Explainambiguity Think Tank affronta le ambiguità dell’IA nei settori farmaceutico e sanitario, promuovendo chiarezza, innovazione e conformità normativa. Mira a rafforzare fiducia, trasparenza ed efficienza, trasformando le complessità in opportunità di crescita. L’obiettivo è un futuro sanitario più sicuro e innovativo, guidato dalla comprensione e dall’applicazione responsabile dell’IA.
Vincenzo Gioia, Remco Jan Geukes Foppen.
Healthcare Innovation Forum
Healthcare Innovation Forum
Rome, Italy, March 26, 2025
https://healthcareinnovationforum.itIl Think Tank Explainambiguity ha presentato un framework che ridefinisce il ruolo dell'intelligenza artificiale nella sanità. La creazione di valore attraverso l’IA sanitaria passa dalla creazione del giusto livello di fiducia tra uomo e IA. Questa fiducia è ottenuta tramite la spiegabilità, il fulcro del framework, che garantisce trasparenza, sicurezza e conformità normativa.
Vincenzo Gioia, Remco Jan Geukes Foppen.
https://healthcareinnovationforum.itIl Think Tank Explainambiguity ha presentato un framework che ridefinisce il ruolo dell'intelligenza artificiale nella sanità. La creazione di valore attraverso l’IA sanitaria passa dalla creazione del giusto livello di fiducia tra uomo e IA. Questa fiducia è ottenuta tramite la spiegabilità, il fulcro del framework, che garantisce trasparenza, sicurezza e conformità normativa.
Vincenzo Gioia, Remco Jan Geukes Foppen.
Page updated
Google Sites
Report abuse